Experience with erlotinib in the treatment of non-small cell lung cancer
L Landi, F Cappuzzo - Therapeutic Advances in Respiratory …, 2015 - journals.sagepub.com
Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related deaths. In
the last decade, the epidermal growth factor receptor (EGFR) signalling pathway has …
the last decade, the epidermal growth factor receptor (EGFR) signalling pathway has …
Experience with erlotinib in the treatment of non-small cell lung cancer
L Landi, F Cappuzzo - Therapeutic advances in …, 2015 - pubmed.ncbi.nlm.nih.gov
Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related deaths. In
the last decade, the epidermal growth factor receptor (EGFR) signalling pathway has …
the last decade, the epidermal growth factor receptor (EGFR) signalling pathway has …
Experience with erlotinib in the treatment of non-small cell lung cancer.
L Landi, F Cappuzzo - Therapeutic Advances in Respiratory …, 2015 - europepmc.org
Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related deaths. In
the last decade, the epidermal growth factor receptor (EGFR) signalling pathway has …
the last decade, the epidermal growth factor receptor (EGFR) signalling pathway has …
Experience with erlotinib in the treatment of non-small cell lung cancer.
L Landi, F Cappuzzo - Therapeutic Advances in Respiratory …, 2015 - search.ebscohost.com
Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related deaths. In
the last decade, the epidermal growth factor receptor (EGFR) signalling pathway has …
the last decade, the epidermal growth factor receptor (EGFR) signalling pathway has …
Experience with erlotinib in the treatment of non-small cell lung cancer
L Landi, F Cappuzzo - Therapeutic Advances in Respiratory Disease, 2015 - cir.nii.ac.jp
抄録< jats: p> Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-
related deaths. In the last decade, the epidermal growth factor receptor (EGFR) signalling …
related deaths. In the last decade, the epidermal growth factor receptor (EGFR) signalling …